Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-04-02 to 2025-04-03
Current total value of award: $2796.81
Description: 4567785641!QUILLIVANT XR 25 MG/5 ML SUSP 120ML